Загрузка...
Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review)
Duchenne muscular dystrophy (DMD) is the most common degenerative neuromuscular disease. The incidence of DMD in live births is 1/3,600-1/6,000. Although glucocorticoid-dependent medication is the mainstay treatment option for DMD, a standard treatment regimen has yet to be determined. The present r...
Сохранить в:
| Опубликовано в: : | Exp Ther Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967797/ https://ncbi.nlm.nih.gov/pubmed/33777191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9875 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|